Jin David — SEC insider filings
SEC reporting owner CIK 1930732. 17 insider filings on record with FilingPulse; latest filed 2026-11-19.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2022-10-28 to 2026-11-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 7 legs across 5 filings — 89,280 shares, $124,601 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: purchase of 25,000 shares @ $1.91 ($47,798) in Fortress Biotech, Inc., filed 2026-11-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | Chief Financial Officer | 14 | 6 legs · 89,033 sh · $124,363 | — | 10 |
| MUSTANG BIO, INC. (MBIO) | Director | 1 | 1 leg · 247 sh · $238 | — | — |
| AVENUE THERAPEUTICS, INC. (ATXI) | Interim PFO and COO | 2 | — | — | 2 |
Insider filings — Jin David
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-19 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 15,000 @ $1.72 · Purchase (P): 25,000 @ $1.91 · Purchase (P): 7,605 @ $1.87 | EDGAR |
| 2026-10-01 | 4 | Fortress Biotech, Inc. (FBIO) | Grant/award (A): 1,190 @ $1.82 | EDGAR |
| 2026-06-24 | 4 | Fortress Biotech, Inc. (FBIO) | Grant/award (A): 400,000 @ $0 | EDGAR |
| 2026-04-01 | 4 | Fortress Biotech, Inc. (FBIO) | Grant/award (A): 2,967 @ $2.18 | EDGAR |
| 2025-12-30 | 4 | MUSTANG BIO, INC. (MBIO) | Purchase (P): 247 @ $0.96 | EDGAR |
| 2025-10-02 | 4 | Fortress Biotech, Inc. (FBIO) | Grant/award (A): 2,711 @ $1.31 | EDGAR |
| 2025-04-01 | 4 | Fortress Biotech, Inc. (FBIO) | Grant/award (A): 5,000 @ $1.22 | EDGAR |
| 2024-12-23 | 4 | Fortress Biotech, Inc. (FBIO) | Grant/award (A): 1,000,000 @ $0 | EDGAR |
| 2024-10-01 | 4 | Fortress Biotech, Inc. (FBIO) | Grant/award (A): 2,625 @ $1.23 | EDGAR |
| 2024-09-25 | 4 | AVENUE THERAPEUTICS, INC. (ATXI) | Grant/award (A): 65,000 @ $0 | EDGAR |
| 2024-07-12 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 500 @ $7.50 | EDGAR |
| 2024-04-02 | 4 | Fortress Biotech, Inc. (FBIO) | Grant/award (A): 2,352 @ $1.70 | EDGAR |
| 2023-12-22 | 4 | Fortress Biotech, Inc. (FBIO) | Grant/award (A): 140,000 @ $0 | EDGAR |
| 2023-07-05 | 4 | AVENUE THERAPEUTICS, INC. (ATXI) | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2023-02-14 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 35,928 @ $0.83 | EDGAR |
| 2022-12-02 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 5,000 @ $0.56 | EDGAR |
| 2022-10-28 | 4 | Fortress Biotech, Inc. (FBIO) | Grant/award (A): 1,350,000 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1930732 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs